
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cappuccino CRISPR/Cas9 KO Plasmid (h) | sc-407008 | 20 µg | $397.00 |
Human BLOC1S4 encodes cappuccino, a core component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1), which coordinates endosomal membrane trafficking and cargo sorting required for specialized organelle maturation. BLOC-1 function supports vesicle budding, recycling, and delivery of protein cargo through the endosome–lysosome system, impacting processes such as pigment granule biogenesis and secretory pathways in specialized cells. Disruption of BLOC-1 subunits perturbs intracellular transport and vesicular dynamics, with relevance to disorders involving lysosome-related organelles and broader neurodevelopmental and synaptic phenotypes linked to endosomal trafficking dysfunction. As a result, BLOC1S4 is commonly studied in the context of endosomal sorting, organelle biogenesis, and pathway-level consequences of altered membrane trafficking.
Cappuccino CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the BLOC1S4 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the BLOC1S4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the BLOC1S4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Cappuccino protein expression.
This CRISPR knockout system enables efficient generation of BLOC1S4-deficient cell models for investigation of Cappuccino signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.